Herpes Simplex Induced Colitis Complicating Ulcerative Colitis: A Case Report

Document Type : Case Report

Authors

1 Assistant Professor, Department of Internal Medicine, Shariati Hospital, Islamic Azad University, Najafabad Branch, Isfahan, Iran

2 Student of Medicine, School of Medicine, Islamic Azad University, Najafabad Branch, Isfahan, Iran

Abstract

Background: Herpes simplex virus (HSV) is a virus rarely can involve the gastrointestinal tract, particularly in individuals with underlying endogenous or exogenous immunosuppressant.Case Report: Patient, a 26-year old man with a history of ulcerative colitis was referred with severe abdominal pain, treat-refractory hematochezia and use of simultaneous immunosuppressive drug. Once suspected and investigated, HSV was known to be the cause of the acute episode. Therefore, the patient underwent treatment with acyclovir whereupon in a matter of days his symptoms healed.Conclusion: Today, HSV is considered as the cause of fulminant attack or resistance of inflamatory bowel diseases to immunomodulator treatment; it can be identified using immunohistochemistry and polymerase chain reaction of tissue samples. Timely antiviral therapy can prevent severe attacks and damage.

Keywords


  1. Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006; 296(8): 964-73.
  2. Baumgart DC. Crohn's disease and ulcerative colitis: from epidemiology and immunobiology to a rational diagnostic and therapeutic approach. New York, NY: Springer; 2012. p. 648.
  3. Slifkin M, Doron S, Snydman DR. Viral prophylaxis in organ transplant patients. Drugs 2004; 64(24): 2763-92.
  4. Aberra FN, Lichtenstein GR. Methods to avoid infections in patients with inflammatory bowel disease. Inflamm Bowel Dis 2005; 11(7): 685-95.
  5. Rahier JF, Ben-Horin S, Chowers Y, Conlon C, De MP, D'Haens G, et al. European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2009; 3(2): 47-91.
  6. Toruner M, Loftus EV, Jr., Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 2008; 134(4): 929-36.
  7. Zamani F, Mohamadnejad M. Herpes simplex virus encephalitis during immunosuppressive treatment of ulcerative colitis. Med Gen Med 2004; 6(4): 7.
  8. Schunter MO, Walles T, Fritz P, Meyding-Lamade U, Thon KP, Fellermann K, et al. Herpes simplex virus colitis complicating ulcerative colitis: A case report and brief review on superinfections. J Crohns Colitis 2007; 1(1): 41-6.
  9. el-Serag HB, Zwas FR, Cirillo NW, Eisen RN. Fulminant herpes colitis in a patient with Crohn's disease. J Clin Gastroenterol 1996; 22(3): 220-3.
  10. Blaszyk H, Hyman NH, Cooper K. Herpes simplex virus colitis in ulcerative colitis, simulating malignancy. Histopathology 2006; 49(3): 316-8.
  11. Ruther U, Nunnensiek C, Muller HA, Rupp W, Gforer S, Bader H, et al. [Herpes simplex-associated exacerbation of Crohn's disease. Successful treatment with acyclovir]. Dtsch Med Wochenschr 1992; 117(2): 46-50.
  12. Loftus EV, Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004; 126(6): 1504-17.
  13. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347(6): 417-29.
  14. Goodgame RW. Gastrointestinal cytomegalovirus disease. Ann Intern Med 1993; 119(9): 924-35.
  15. Papadakis KA, Tung JK, Binder SW, Kam LY, Abreu MT, Targan SR, et al. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol 2001; 96(7): 2137-42.
  16. Watanabe T. Ulcerative colitis that developed 8 years after human parvovirus B19 encephalopathy. Eur J Pediatr 2004; 163(6): 341-2.
  17. Gehlert T, Devergne O, Niedobitek G. Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease. J Med Virol 2004; 73(3): 432-8.
  18. Wakefield AJ, Fox JD, Sawyerr AM, Taylor JE, Sweenie CH, Smith M, et al. Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol 1992; 38(3): 183-90.
  19. Colemont LJ, Pen JH, Pelckmans PA, Degryse HR, Pattyn SR, Van Maercke YM. Herpes simplex virus type 1 colitis: an unusual cause of diarrhea. Am J Gastroenterol 1990; 85(9): 1182-5.
  20. Buss DH, Scharyj M. Herpesvirus infection of the esophagus and other visceral organs in adults. incidence and clinical significance. Am J Med 1979; 66(3): 457-62.
  21. Matsumoto J, Sumiyoshi A. Herpes simplex esophagitis--a study in autopsy series. Am J Clin Pathol 1985; 84(1): 96-9.
  22. Fatahzadeh M, Schwartz RA. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J Am Acad Dermatol 2007; 57(5): 737-63.
  23. Gupta R, Warren T, Wald A. Genital herpes. Lancet 2007; 370(9605): 2127-37.
  24. Smith JO, Sterling RK, Mills AS, Stravitz RT, Luketic VA, Fuchs M, et al. Herpes simplex virus colitis in a patient with Crohn's disease and hepatitis B and d cirrhosis. Gastroenterol Hepatol (N Y) 2010; 6(2): 120-2.
  25. Dray X, Treton X, Mazeron MC, Lavergne-
  26. Slove A, Joly F, Mimram D, et al. Herpes simplex virus type 1 colitis in a patient with common variable immunodeficiency syndrome. Eur J Gastroenterol Hepatol 2006; 18(5): 541-4.
  27. Fillet AM. Prophylaxis of herpesvirus infections in immunocompetent and immunocompromised older patients. Drugs Aging 2002; 19(5): 343-54.
  28. Whitley RJ, Gnann JW, Jr. Acyclovir: a decade later. N Engl J Med 1992; 327(11): 782-9.
  29. Chevaux JB, Peyrin-Biroulet L. Herpes simplex virus colitis complicating the course of a patient with Crohn's disease and cirrhosis: an underestimated association? Gastroenterol Hepatol (N Y) 2010; 6(2): 122-4.